## Abstract ## Purpose To evaluate the potential of a new lipophilic paramagnetic complex [Gd(Bz‐TTDA)]^2–^ [(4s)‐4‐benzyl‐3,6,10‐tri(carboxymethyl)‐3,6,10‐triazadodecandioic acid]^2–^ designed for use as a hepatobiliary MR contrast agent. ## Materials and Methods MR imaging studies for normal a
Enhancement effects of a hepatocyte receptor—specific MR contrast agent in an animal model
✍ Scribed by William C. Small; Rendon C. Nelson; Gillian M. Sherbourne; Michael E. Bernardino
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 905 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The enhancement characteristics of the liver and spleen produced by a hepatocyte‐specific magnetic resonance imaging agent, an arabinogalactan‐coated ultrasmall superparamagnetic iron oxide derivative, BMS 180550, were evaluated. Both heavily T1‐ and T2‐weighted sequences were used. Imaging was performed in the farm pig model, as a function of contrast agent concentration (5, 10, and 20 μmol of iron per kilogram) and delay (immediate, 0.5, 2.5, 5.0, 7.5, and 9.0 hours) after bolus injection of BMS 180550. BMS 180550 provided excellent contrast enhancement characteristics by producing marked positive enhancement with T1‐weighted sequences and marked negative enhancement with T2‐weighted sequences. The T1‐weighted enhancement immediately after contrast agent injection was of greater magnitude in the spleen (329% ± 83) than in the liver (66% ± 16). Postcontrast negative enhancement with T2‐weighted sequences was largely hepatocyte specific at 5 and 10 μmol/kg but was also seen within the spleen at 20 μmol/kg. The authors discuss the possible mechanisms that produce these changes and conclude that 10 μmol/kg BMS 180550 is near the optimum dose for maximizing the enhancement properties of this agent with all sequences in the farm pig.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To assess whether Gd‐DTPA‐Gel‐Cis, a conjugate of gadolinium (Gd), cis diamminedichloroplatinum (Cis), diethylenetriaminepentaacetic acid (DTPA)‐dianhydride, and bovine gelatin (Gel) can be used as an intravascular contrast agent at MRI and as an antitumor cell proliferation
## Abstract ## Purpose To investigate the duration of liver R2\* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle in a rat model. ## Materials and Methods Rats were injected with 0, 1, 2, or 5 mg Fe/kg of NC100150 Injection, and quantitative in vivo 1/T2\*
## Abstract ## Purpose To determine the diagnostic value of a new ultrasmall superparamagnetic iron oxide Clariscan®, (NC100150) for the evaluation of renal perfusion in an animal model using a 3D‐FFE‐EPI sequence. ## Materials and Methods Four groups of four rabbits each were imaged after bolus